Early Events in Mammalian B-Cell Differentiation

哺乳动物 B 细胞分化的早期事件

• 批准号: 7814397
• 负责人: Paul Wayne Kincade
• 金额: $ 32.6万
• 依托单位: OKLAHOMA MEDICAL RESEARCH FOUNDATION
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-28 至 2011-09-27
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7814397
• 关键词: Accounting; Animal Model; Autoimmune Process; B cell differentiation; Back; Bioinformatics; Blood; Blood Cells; Cells; Centers of Research Excellence; Core Facility; Disease; Event; Faculty; Grooming; Hematopoiesis; Hematopoietic; Human; Human Resources; Immune system; Instruction; Investigation; Malignant - descriptor; Malignant Neoplasms; Mentors; Methods; National Center for Research Resources; Nature; Parents; Participant; Progress Reports; Property; Protocols documentation; Public Health; Publications; Research; Research Design; Research Personnel; Science; Specimen; Stem cells; Testing; Tumor Stem Cells; bone; innovation; member; parent project; progenitor; programs; research study

DESCRIPTION (provided by applicant): Specifically, it is a request to add a third Specific Aim, "To study lineage stability and directionality of hematopoiesis", to an ongoing project, AI-20069, entitled "Early Events in Mammalian B-Cell Differentiation". The experiments will rigorously test a new concept, i.e. that primitive hematopoietic cells can reverse differentiation and re-acquire some stem cell properties. Indeed, stem cells may normally oscillate between states before giving rise to lineage restricted progenitors. The same phenomenon could account for the ability of malignancies to retain rare tumor stem cells. A better understanding of the stability of blood forming cells will be informative about how the immune system is replaced in normal and disease circumstances. Given the innovative nature of the concept, the experiments may open an entirely new line of investigation. However, we need additional personnel and supplies, as well as bioinformatics and microarray support that can be obtained by affiliation with OMRF's NCRR supported COBRE, entitled "Science in a Culture of Mentoring (RR015577)". This COBRE has a proud record in mentoring and networking, as well as superb Core Facilities. Thus, the outstanding young investigator to be covered by this supplement will benefit from interactions with this COBRE and be groomed for eventual status as an independent faculty member. In addition, the PI of the parent RO1 will contribute expertise and mentoring to other participants in the COBRE. Animal models, normal human specimens and protocols are all ready to be used immediately, and the research plan can be completed in two years. PUBLIC HEALTH REVELANCE: Cells in the immune system are constantly replaced from rare stem cells that reside within bones. It has always been believed that this occurs in one direction, from stem cell to blood cell. However, exciting new findings suggest there is a degree of back and forth. More study could suggest new therapies for autoimmune, malignant and other diseases involving the immune system.

描述（由申请人提供）：具体而言，请求将第三个具体目的“研究造血的谱系稳定性和方向性”添加到正在进行的项目AI-20069中，标题为“哺乳动物B细胞分化的早期事件”。这些实验将严格测试一个新概念，即原始造血细胞可以逆转分化并重新获得某些干细胞特性。事实上，干细胞在产生谱系限制的祖细胞之前通常会在状态之间振荡。同样的现象可以解释恶性肿瘤保留罕见肿瘤干细胞的能力。更好地了解造血细胞的稳定性将有助于了解免疫系统在正常和疾病情况下是如何被取代的。鉴于这一概念的创新性质，这些实验可能会开辟一条全新的研究路线。然而，我们需要额外的人员和物资，以及生物信息学和微阵列的支持，可以通过隶属于OMRF的NCRR支持的COBRE，题为“科学在文化的指导（RR 015577）"。这个COBRE在指导和网络方面有着令人自豪的记录，以及一流的核心设施。因此，优秀的年轻研究者将被本补充所涵盖，将受益于与本COBRE的互动，并被培养为最终的地位，作为一个独立的教员。此外，母RO 1的PI将为COBRE的其他参与者提供专业知识和指导。动物模型、正常人体标本和方案都可以立即使用，研究计划可以在两年内完成。 公共卫生革命：免疫系统中的细胞不断被骨骼中的稀有干细胞取代。人们一直认为，这发生在一个方向，从干细胞到血细胞。然而，令人兴奋的新发现表明，存在一定程度的来回。更多的研究可能会为自身免疫性疾病、恶性肿瘤和其他涉及免疫系统的疾病提供新的治疗方法。